W. Kimryn Rathmell (born November 3, 1969) is an Americanphysician-scientist whose work focuses on the research and treatment of patients with kidney cancers. She served as the 17th Director of the National Cancer Institute from 2023 to 2025, having previously served as the Hugh Jackson Morgan Professor and Chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), and Physician-in-Chief for Vanderbilt University Adult Hospital and Clinics in Nashville, Tennessee. On November 17, 2023, Rathmell was nominated by President Biden as the next Director of the National Cancer Institute and she assumed office on December 18, 2023. She stepped down from her role as director on January 20, 2025. It was announced she would assume the role of CEO of the James Cancer Hospital in Columbus, Ohio effective May 27, 2025.
Provided by Wikipedia
W. Kimryn Rathmell (born November 3, 1969) is an American physician-scientist whose work focuses on the research and treatment of patients with kidney cancers. She served as the 17th Director of the National Cancer Institute from 2023 to 2025, having previously served as the Hugh Jackson Morgan Professor and Chair of the Department of Medicine at Vanderbilt University Medical Center (VUMC), and Physician-in-Chief for Vanderbilt University Adult Hospital and Clinics in Nashville, Tennessee. On November 17, 2023, Rathmell was nominated by President Biden as the next Director of the National Cancer Institute and she assumed office on December 18, 2023. She stepped down from her role as director on January 20, 2025. It was announced she would assume the role of CEO of the James Cancer Hospital in Columbus, Ohio effective May 27, 2025.
Provided by Wikipedia